Biosimilars and biologics : implementation and monitoring in a healthcare setting /

Mostrar otras versiones (1)

Get Up to Speed on the Fastest Growing Pharmaceutical Innovation With the Only Guide Written for Pharmacists Among the most anticipated and discussed segments of the pharmaceutical market, biosimilars, are finally beginning to exert a greater impact on practice. To meet the growing need for informat...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Lucio, Steven (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Bethesda, MD : American Society of Health-System Pharmacists, Inc., [2018]
Temas:
Pharmaceutical biotechnology.
Pharmaceutical biotechnology industry.
Drugs > Generic substitution.
Pharmaceutical policy.
Biological products.
Biosimilar Pharmaceuticals
Drug Compounding
Drug Monitoring
Biological Factors
Biotechnologie pharmaceutique.
Biotechnologie pharmaceutique > Industrie.
Médicaments > Dénomination commune.
Médicaments > Politique gouvernementale.
Produits biologiques.
Médicaments biosimilaires.
Pharmacovigilance.
MEDICAL > Pharmacology.
Biological products
Drugs > Generic substitution
Pharmaceutical biotechnology
Pharmaceutical biotechnology industry
Pharmaceutical policy
Acceso en línea:Texto completo
Tabla de Contenidos:
  • A new type of blockbuster : the growth of biologics
  • Déjá vu or something new? : comparing the generics and biosimilars experiences
  • Bugs and drugs, and yeast and mice, and Chinese hamsters
  • The $250 billion pyramid : analytics in biosimilarity determination
  • The global biosimilars experience
  • The American biosimilar experience : red, white, and possibly interchangeable
  • Biosimilar clinical trial requirements
  • Immunogenicity and pharmacovigilance in the biosimilar era
  • The patent dance and the exclusivity shuffle
  • Defining biosimilar value and other impossible tasks
  • Biosimilar formulary management strategies.

Ejemplares similares